Average Co-Inventor Count = 5.32
ph-index = 6
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. National Institutes of Health, a Component of the US Dept. of Health & Human Services (17 from 3,435 patents)
17 patents:
1. 11753627 - Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3'-UTR of dengue types 1,2,3, and 4, or antigenic chimeric dengue viruses 1,2,3, and 4
2. 11318196 - Attenuated mutant dengue viruses comprising a mutation in the NS5 non-structural protein
3. 10837003 - Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3'-utr of dengue types 1, 2, 3, and 4, or antigenic chimeric dengue viruses 1, 2, 3, and 4
4. 10500264 - Development of mutations useful for attenuating dengue viruses and chimeric dengue viruses
5. RE46641 - Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3'-UTR of dengue types 1,2,3, and 4, or antigenic chimeric dengue viruses 1,2,3, and 4
6. RE46631 - Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3'-UTR of dengue types 1,2,3, and 4, or antigenic chimeric dengue viruses 1,2,3, and 4
7. 9783787 - Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3'-UTR of dengue types 1, 2, 3, and 4, or antigenic chimeric dengue viruses 1, 2, 3, and 4
8. 9707287 - Attenuated mutant dengue viruses comprising a mutation in the NS4B non-structural protein
9. RE45123 - Recombinant attenuated dengue viruses comprising a deletion in the 3' untranslated region and additional attenuating mutations induced by chemical mutagenesis
10. RE45053 - Attenuated dengue virus comprising mutations in the NS3 gene
11. RE45016 - Development of mutations useful for attenuating dengue viruses and chimeric dengue viruses
12. 8632782 - Recombinant attenuated dengue viruses comprising mutations in NS5 and the 3' untranslated region
13. 8075903 - Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3'-UTR of dengue types 1, 2, 3, and 4 or antigenic chimeric dengue viruses 1, 2, 3, and 4
14. 8039003 - Recombinant attenuated dengue viruses comprising a deletion in the 3' untranslated region and additional attenuating mutations induced by chemical mutagenesis
15. 7560118 - Attenuated dengue virus comprising mutations in the NS3 gene